Fig. 3.
Overall survival curve in all patients. a: The patients who had tumors with Nrf2 gene mutation (+) showed shorter overall survival. b: The patients who had tumors with C/A or A/A genotype showed unfavorable overall survival. c: The patients with higher Nrf2 expression in the primary tumor showed worse overall survival. d: The Keap1 gene mutation was not associated with overall survival